Industry
Medical - Devices
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 11:31 am
Portfolio Pulse from Benzinga Newsdesk
August 07, 2024 | 5:52 pm
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 12:01 pm
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 11:51 am
Portfolio Pulse from Benzinga Newsdesk
July 22, 2024 | 8:05 pm
Portfolio Pulse from Benzinga Newsdesk
June 17, 2024 | 11:36 am
Portfolio Pulse from Benzinga Newsdesk
June 10, 2024 | 11:35 am
Portfolio Pulse from Benzinga Newsdesk
June 05, 2024 | 10:28 am
Portfolio Pulse from Benzinga Newsdesk
June 03, 2024 | 11:33 am
Portfolio Pulse from Benzinga Newsdesk
May 09, 2024 | 4:51 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.